hydrochloric acid has been researched along with Dysmyelopoietic Syndromes in 1 studies
Hydrochloric Acid: A strong corrosive acid that is commonly used as a laboratory reagent. It is formed by dissolving hydrogen chloride in water. GASTRIC ACID is the hydrochloric acid component of GASTRIC JUICE.
hydrogen chloride : A mononuclear parent hydride consisting of covalently bonded hydrogen and chlorine atoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raza, A | 1 |
| Galili, N | 1 |
| Callander, N | 1 |
| Ochoa, L | 1 |
| Piro, L | 1 |
| Emanuel, P | 1 |
| Williams, S | 1 |
| Burris, H | 1 |
| Faderl, S | 1 |
| Estrov, Z | 1 |
| Curtin, P | 1 |
| Larson, RA | 1 |
| Keck, JG | 1 |
| Jones, M | 1 |
| Meng, L | 1 |
| Brown, GL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 1-2a Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome[NCT00035867] | Phase 1/Phase 2 | 65 participants | Interventional | 2002-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for hydrochloric acid and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Glu | 2009 |